Correlation Between Algernon Pharmaceuticals and Accustem Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and Accustem Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and Accustem Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Algernon Pharmaceuticals and Accustem Sciences, you can compare the effects of market volatilities on Algernon Pharmaceuticals and Accustem Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of Accustem Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and Accustem Sciences.

Diversification Opportunities for Algernon Pharmaceuticals and Accustem Sciences

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Algernon and Accustem is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and Accustem Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accustem Sciences and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with Accustem Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accustem Sciences has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and Accustem Sciences go up and down completely randomly.

Pair Corralation between Algernon Pharmaceuticals and Accustem Sciences

Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 41.62 times less return on investment than Accustem Sciences. But when comparing it to its historical volatility, Algernon Pharmaceuticals is 1.58 times less risky than Accustem Sciences. It trades about 0.0 of its potential returns per unit of risk. Accustem Sciences is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  28.00  in Accustem Sciences on September 24, 2024 and sell it today you would lose (4.00) from holding Accustem Sciences or give up 14.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.4%
ValuesDaily Returns

Algernon Pharmaceuticals  vs.  Accustem Sciences

 Performance 
       Timeline  
Algernon Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Algernon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Accustem Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Accustem Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Algernon Pharmaceuticals and Accustem Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Algernon Pharmaceuticals and Accustem Sciences

The main advantage of trading using opposite Algernon Pharmaceuticals and Accustem Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, Accustem Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accustem Sciences will offset losses from the drop in Accustem Sciences' long position.
The idea behind Algernon Pharmaceuticals and Accustem Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data